The American Hospital Association sued the Trump administration again over a plan to revamp the federal 340B drug discount program into after-the-fact rebates instead of upfront discounts. A 2025 suit halted a 10-drug pilot HHS later withdrew after losing on appeal; an expanded version targeting 25